Pergolide:: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS).: Longterm follow up on pergolide -: Short communication

被引:26
|
作者
Staedt, J [1 ]
Hünerjäger, H [1 ]
Rüther, E [1 ]
Stoppe, G [1 ]
机构
[1] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany
关键词
restless legs syndrome; RLS; nocturnal myoclonus syndrome; NMS; pergolide; longterm treatment;
D O I
10.1007/s007020050055
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good effects after averagely 517 treatment days.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 50 条